A possible probiotic (S. salivarius K12) approach to improve oral and lung microbiotas and raise defenses against SAR S-CoV-2.

Di Pierro, Francesco

Di Pierro, Francesco.

Di Pierro F; Velleja Research, Milan, Italy - f.dipierro@vellejaresearch.com.

Minerva Med ; 111(3): 281-283, 2020 06.

Article in English | MEDLINE | ID: covidwho-685818

Subject(s)

Coronavirus Infections/prevention & control; Lung/microbiology; Microbiota; Mouth/microbiology; Pandemics/prevention & control; Pneumonia, Viral/prevention & control; Probiotics/therapeutic use; Streptococcus salivarius; COVID-19; Humans; Lung/immunology; Microbiota/immunology; Mouth/immunology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Probiotics / Pandemics / Microbiota / Streptococcus salivarius / Lung / Mouth Limits: Humans Language: English Journal: Minerva Med Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google